- Home
- REBN vs HIND Comparison
REBN vs HIND Comparison
Compare REBN & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REBN | HIND |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3M | 12.9M |
| IPO Year | 2017 | 2016 |
Fundamental Metrics
Financial Performance| Metric | REBN | HIND |
|---|---|---|
| Price | $1.94 | $2.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 51.8K | 49.7K |
| Earning Date | 03-27-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,928,533.00 | N/A |
| Revenue This Year | $335.98 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.36 | $1.75 |
| 52 Week High | $4.14 | $12.87 |
Technical Indicators
Market Signals| Indicator | REBN | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 55.95 | 40.69 |
| Support Level | $1.59 | $2.02 |
| Resistance Level | $1.98 | $2.93 |
| Average True Range (ATR) | 0.11 | 0.19 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 66.67 | 28.87 |
Price Performance
Historical ComparisonAbout REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.
About HIND Vyome Holdings Inc.
Vyome Holdings Inc is a reseach and development company. The Company operates in two segments, biotechnology and pharmaceutical products. The biotechnology segment comprises of operations around VT-1953, VT-1908, and VB-1953 programs that are in development, and the pharmaceutical segment comprises of antifungal products manufacturing and distribution.